RIL
VYNT

Rothschild Investment LLC’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Rothschild Investment LLC’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-80
Closed -$136K – 511
2014
Q2 		$136K Hold
80
– – 0.02% 401
2014
Q1 		$181K Sell
80
-128
-62% -$328K 0.02% 390
2013
Q4 		$430K Buy
+208
New +$449K 0.06% 293

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.45B AUM 5.8% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Rothschild Investment LLC's VYNT Position: Q3 2014 in Review

Rothschild Investment LLC sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2014, closing a stake of 80 shares — an estimated $136K sold.

Rothschild Investment LLC first reported a position in VYNT in Q4 2013 and held it in 3 quarters. The position peaked at $430K in Q4 2013. 28 funds tracked by Wall St. Rank hold VYNT as of Q3 2014.

  • Rothschild Investment LLC reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Rothschild Investment LLC sold 80 Vyant Bio, Inc. Common Stock shares in Q3 2014, an estimated $136K.
  • Rothschild Investment LLC first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • Rothschild Investment LLC's Vyant Bio, Inc. Common Stock position peaked at $430K in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2014.

Based on Rothschild Investment LLC's 13F filing for Q3 2014, filed 24 Oct 2014.